This article contains AI generated content.
Medial Tibial Condyle Chondropathy: 4 Genes And 7 Biomarkers To Track
Introduction
A diagnosis like medial tibial condyle chondropathy tends to arrive with more questions than answers. You know exactly where the pain is — the inner side of the knee, often worse going down stairs or after a long walk — and you may have an MRI report describing cartilage thinning or fissuring on the medial tibial plateau. What you usually don't get is a clear explanation of why that specific patch of cartilage is breaking down while the rest of the joint looks fine, or what you can actually do about it beyond "lose weight, strengthen your quads, and see how it goes."
That generic advice isn't wrong, but it's incomplete. Cartilage health is downstream of things that don't show up on an X-ray: how much background inflammation your body is carrying, whether your metabolism is quietly stressing the joint through elevated blood sugar and insulin, whether you have enough vitamin D and omega-3s to support tissue repair, and in some cases, inherited variants in genes that shape how cartilage is built and maintained. Two people with identical alignment and identical X-rays can have very different biological environments inside that joint.
This article takes a more mechanistic approach. Instead of stopping at "manage your weight and strengthen the muscles around the knee," it looks at the specific lab values worth tracking, what each one may be telling you about the biology driving cartilage wear, and what a realistic response looks like — with and without supplements — for anyone who wants to be more deliberate about protecting the cartilage they still have.
None of this replaces an orthopedic or rheumatology evaluation, and no biomarker panel or gene test will regrow lost cartilage. But better information changes decisions. Knowing your inflammatory and metabolic profile can tell you whether your knee pain is a local mechanical problem, a systemic one, or both — and that distinction changes what's worth doing next. The main focus here is on trackable biomarkers, since they reflect what's happening in your body right now and can be re-measured to check progress. A shorter section also covers what current genetics research suggests, plus a look at a widely read longevity book and a set of complementary approaches with real supporting studies.
Summary
Most of what drives cartilage breakdown at the medial tibial plateau never shows up on imaging: a mildly elevated inflammatory marker, a fasting insulin level that's crept up over the years, a vitamin D level that's "normal" but not optimal, or an inherited variant that makes your cartilage matrix a little less resilient than average. This article walks through seven biomarkers — from a basic hs-CRP test you can order for under thirty dollars to specialized cartilage-breakdown markers like COMP and CTX-II — and explains what each one may reveal about the biology behind your knee pain, how to measure it, and what a realistic improvement plan looks like, with and without supplements. It then covers four genes with real (if still evolving) human evidence linking them to osteoarthritis susceptibility, what a "bad" version of each might mean in practice, and how it can often be worked around through lifestyle rather than treated as fate. A summary of ideas from Peter Attia's Outlive follows, focused on the parts of the book most relevant to joint longevity, along with a review of complementary approaches — tai chi, yoga, massage, biofeedback, and photobiomodulation — that have actual clinical trials behind them for knee osteoarthritis rather than just anecdotal support.
The Biomarkers That Actually Explain What's Happening In Your Knee
Most research on cartilage biomarkers has been done in the context of knee osteoarthritis broadly, not isolated medial tibial condyle lesions specifically. That's a real limitation worth naming upfront. But the medial tibial plateau is the single most common site of cartilage loss in the knee — it bears roughly 60-70% of load through the joint during standing and walking — so the biology of knee OA biomarker research applies directly to this location. The National Institute of Arthritis and Musculoskeletal and Skin Diseases notes that osteoarthritis develops through active tissue breakdown and remodeling, not simple mechanical wear — which is exactly why blood and urine markers of that biology are worth tracking.
The following seven biomarkers cover three angles on the problem: systemic inflammation, metabolic stress, and direct cartilage turnover. Between them, they give a much clearer picture than pain scores or X-rays alone.
High-Sensitivity C-Reactive Protein (hs-CRP)
Why it matters: hs-CRP is a general marker of low-grade systemic inflammation. In people with early knee osteoarthritis, modestly elevated CRP has been associated with faster symptom progression over several years, and a meta-analysis found CRP levels are consistently higher in people with clinical knee OA compared to those without it, even though it performs only moderately well on its own as a diagnostic marker. It doesn't tell you inflammation is happening in your knee specifically — it tells you your whole body is running a slightly hotter inflammatory baseline, which affects every joint, including the one already under mechanical stress.
How to measure it: A standard blood draw, available through almost any primary care provider or direct-to-consumer lab service. Cost typically runs $10-$30 out of pocket if ordered without insurance, and it's usually part of any comprehensive metabolic panel add-on.
If the score is bad, the plan without supplements: Prioritize sleep consistency (7-9 hours, stable wake time), reduce ultra-processed food and added sugar intake, and add two to three sessions per week of zone 2 cardio (an intensity where you can still hold a conversation). These interventions typically show measurable CRP reductions within 8-12 weeks. Recheck every 3 months, not sooner — CRP fluctuates with recent illness or injury and single readings can mislead.
If the score is bad, the plan with supplements or equipment: Omega-3 fish oil (1.5-3g combined EPA/DHA daily, with meals to reduce GI upset) has the best evidence for lowering CRP in people with elevated baseline inflammation. Curcumin (500-1000mg with piperine, daily) has modest supporting evidence for CRP and joint pain but interacts with blood thinners — flag it to your doctor if you take anticoagulants. Cycle re-testing every 3 months; there's no need to cycle the supplements themselves off and on, but reassess necessity annually.
Fasting Insulin And HbA1c (The Metabolic Phenotype)
Why it matters: A growing body of research describes a distinct "metabolic syndrome-associated osteoarthritis" phenotype, where insulin resistance and low-grade systemic inflammation — not just mechanical load — drive cartilage breakdown. Osteoarthritic joint tissue from people with type 2 diabetes shows insulin-resistant features locally, and elevated insulin appears to alter chondrocyte metabolism independent of body weight. This matters because it means a lean person with poor metabolic health can still be accelerating cartilage loss, and a heavier person with excellent metabolic markers may be at lower risk than their weight alone would suggest.
How to measure it: Fasting insulin ($20-$50) and HbA1c ($15-$40) are both standard blood tests. HOMA-IR, a calculated insulin resistance score derived from fasting glucose and insulin, is a more sensitive early-warning marker than HbA1c and worth requesting specifically if it's available through your lab.
If the score is bad, the plan without supplements: Resistance training 2-3x/week is one of the most reliable ways to improve insulin sensitivity, alongside reducing refined carbohydrate load and walking after meals (even 10 minutes measurably blunts post-meal glucose spikes). Time-restricted eating (e.g., a 10-12 hour eating window) has modest supporting evidence for insulin sensitivity in people who aren't already lean and active.
If the score is bad, the plan with supplements or equipment: Berberine (500mg, 2-3x daily with meals) has RCT evidence comparable to some oral hypoglycemics for improving insulin sensitivity, but can cause GI upset and should be cycled — typically 3 months on, with a reassessment before continuing, and it should not be combined with diabetes medication without medical supervision. A continuous glucose monitor (roughly $50-$100/month) is useful short-term (4-8 weeks) to identify which specific foods spike your glucose, rather than as a permanent tool.
Vitamin D (25-Hydroxyvitamin D)
Why it matters: Vitamin D plays a role in cartilage and bone matrix regulation, and observational studies have long linked low vitamin D status to osteoarthritis progression. The evidence for supplementation actually reversing existing cartilage loss is weaker than it once looked — a well-conducted two-year randomized trial found that vitamin D3 supplementation targeting levels above 36 ng/mL did not reduce knee pain or slow cartilage volume loss compared to placebo in people who already had symptomatic knee OA. That's an important, honest caveat: correcting a deficiency is still worthwhile for bone and overall health, but it isn't established as a cartilage-repair strategy once damage is already present.
How to measure it: A standard 25(OH)D blood test, $30-$50, or often bundled into broader wellness panels.
If the score is bad, the plan without supplements: 15-20 minutes of midday sun exposure on bare skin several times a week (adjusted for skin tone and latitude — this is far less effective in winter at higher latitudes), plus dietary sources like fatty fish and egg yolks.
If the score is bad, the plan with supplements or equipment: Vitamin D3, typically 1000-2000 IU daily for maintenance or up to 4000-5000 IU daily short-term to correct a documented deficiency, taken with a fat-containing meal for absorption, alongside vitamin K2 (100mcg) to support proper calcium utilization. Retest at 3 months; oversupplementation (sustained levels above 100 ng/mL) carries a small risk of hypercalcemia, so this isn't a "more is better" nutrient.
Cartilage Oligomeric Matrix Protein (COMP)
Why it matters: COMP is a structural protein released into the bloodstream when cartilage matrix breaks down. A systematic review and meta-analysis found COMP, along with CTX-II and MMP-3, shows moderate diagnostic performance for distinguishing people with knee and hip osteoarthritis from those without it, making it one of the more direct — if imperfect — windows into active cartilage degradation happening right now, rather than inflammation elsewhere in the body.
How to measure it: This is a specialty test, not something a standard primary care panel offers. It requires a lab that runs ELISA-based cartilage biomarker panels, and cost typically runs $100-$250, often only available through research-oriented or concierge functional medicine clinics.
If the score is bad, the plan without supplements: Reducing high-impact loading on the affected knee (deep lunges, running on hard surfaces, deep squats under heavy load) while maintaining strength work in pain-free ranges is the most direct way to reduce ongoing matrix breakdown. Low-impact cardio substitution (cycling, swimming, elliptical) preserves fitness without the repetitive impact.
If the score is bad, the plan with supplements or equipment: Collagen peptides (10-15g daily, typically type II or hydrolyzed collagen, taken with vitamin C which supports collagen synthesis) have modest RCT support for joint symptom improvement, though effects on COMP specifically are less well established. There's no strong reason to cycle collagen; it's generally taken continuously if tolerated, with no notable side effects beyond occasional mild GI upset.
Urinary CTX-II
Why it matters: CTX-II is a breakdown fragment of type II collagen — the main structural collagen in cartilage — excreted in urine. It's considered one of the more OA-specific biomarkers available, showing particularly strong performance for hip OA and moderate performance for knee OA in comparative studies, and it tends to track with radiographic progression over time better than blood inflammatory markers do.
How to measure it: A urine-based specialty test, usually $100-$200, offered through the same specialty/research labs that run COMP panels. It's not widely available through standard commercial labs yet.
If the score is bad, the plan without supplements: Same mechanical-load principles as COMP — reduce peak joint loading, maintain muscle support around the joint through controlled-range strength training, and address any gait or alignment issue (like excessive varus thrust) with a physical therapist, since that mechanical overload is often the direct driver of ongoing collagen breakdown at the medial tibial plateau specifically.
If the score is bad, the plan with supplements or equipment: A hinged knee brace or lateral wedge insole can offload the medial compartment mechanically during the day — inexpensive, low-risk, and directly addresses the "medial" part of medial tibial condyle chondropathy. Glucosamine sulfate (1500mg daily) has mixed but not negligible trial evidence for symptom relief in knee OA; if trying it, give it a full 8-12 week trial before judging effect, since onset is slow, and it's generally well tolerated aside from occasional GI upset.
Uric Acid
Why it matters: The relationship here is more nuanced than a simple "high is bad." Elevated uric acid can activate the NLRP3 inflammasome pathway and has been correlated with joint inflammation and osteophyte formation, particularly in women, though the association is more consistent for hip OA than knee OA in some cohort studies. It's not a primary driver for most people with isolated medial cartilage lesions, but it's worth knowing, especially if you have any history of gout-type symptoms or a diet heavy in purine-rich foods and alcohol.
How to measure it: A basic blood test, $10-$25, often included in standard metabolic panels.
If the score is bad, the plan without supplements: Reduce alcohol (especially beer) and organ meat/shellfish intake, increase water intake, and address any coexisting insulin resistance, since the two often travel together.
If the score is bad, the plan with supplements or equipment: Tart cherry extract (480mg twice daily) has some trial support for lowering uric acid and reducing inflammatory joint symptoms; it's low-risk but should be used continuously for at least 4-6 weeks before evaluating effect, and cycling isn't typically necessary.
Omega-3 Index
Why it matters: Rather than measuring how much fish oil you take, the omega-3 index measures how much EPA/DHA is actually incorporated into your red blood cell membranes — a much better reflection of tissue-level anti-inflammatory status. A meta-analysis of nine randomized trials found omega-3 supplementation produced a statistically significant reduction in osteoarthritis pain compared to placebo, with mechanistic evidence suggesting a protective effect against cartilage loss through reduced inflammatory signaling in joint tissue.
How to measure it: A specialty finger-prick or blood spot test, $40-$75, sold directly to consumers by specialty labs (this is the same test category often marketed as part of comprehensive longevity panels).
If the score is bad, the plan without supplements: Eat fatty fish (salmon, sardines, mackerel) 2-3 times per week; this alone can meaningfully shift the index over 3-4 months.
If the score is bad, the plan with supplements or equipment: A triglyceride-form fish oil supplement (2-3g combined EPA/DHA daily, with food) is well absorbed and low-risk, though high doses can mildly increase bleeding risk — worth flagging if you're on blood thinners or facing surgery. Retest the index at 4 months; there's no need to cycle omega-3 supplementation on and off.
What Your Genes May Be Telling You About Cartilage Resilience
Genetics research on osteoarthritis susceptibility is real and growing, but it's worth being direct about its current limits: most variants identified so far shift risk modestly, they were mostly discovered in specific population studies (often Japanese or Han Chinese cohorts), and none of them determine outcome on their own. Researchers like Ali Torkamani, who has written extensively on how modest genetic risk scores interact with lifestyle, and Gary Brecka, known for popularizing comprehensive biomarker-plus-genetic testing panels, both make the same underlying point: a "risk" gene variant is a nudge in one direction, not a verdict, and it matters far less than what you actually do with your joints, your diet, and your training. That framing is useful here — these four genes are worth knowing, but the biomarker panel above will tell you far more about what's happening right now.
GDF5
GDF5 (growth differentiation factor 5) is involved in joint formation and cartilage development. A specific promoter variant, rs143383, reduces GDF5 gene expression and was found to be strongly associated with both hip and knee osteoarthritis susceptibility across Japanese, Han Chinese, and later European cohorts, in one of the most consistently replicated findings in OA genetics.
If the gene is bad, the plan without supplements: Since GDF5's main effect is on cartilage and joint development rather than something directly modifiable, the practical response is prevention-focused — prioritize joint-protective strength training (especially eccentric quad and hip abductor work) earlier and more consistently than someone without this variant might need to, since your baseline cartilage matrix may be somewhat less robust.
If the score is bad, the plan with supplements or equipment: There's no supplement that compensates for reduced GDF5 expression directly. Collagen peptides and adequate vitamin C and copper intake (both cofactors for collagen crosslinking) support general matrix synthesis, but this is a supportive measure, not a targeted fix — dosing and cycling follow the same pattern described under the COMP biomarker above.
ASPN (Asporin)
ASPN encodes asporin, a cartilage matrix protein. A specific repeat-length variant (the D14 allele) inhibits chondrogenesis and has been associated with increased osteoarthritis susceptibility, first identified in Japanese cohorts and since studied through meta-analysis across other populations with somewhat inconsistent but generally supportive findings, particularly for knee OA.
If the gene is bad, the plan without supplements: Because ASPN's effect is on chondrogenesis (the process of forming new cartilage tissue), the most relevant lever is mechanical — moderate, consistent joint loading (not overloading, not underloading) stimulates the chondrocyte activity that a D14 carrier's cartilage may need more encouragement to sustain. Avoid both prolonged immobilization and high-impact overuse.
If the score is bad, the plan with supplements or equipment: No supplement directly targets asporin function. Some early research suggests glucosamine may modestly support chondrocyte activity in general; if used, follow the same protocol as under CTX-II above, with realistic expectations about modest effect size.
IL-6 Promoter Variants
IL-6 is a pro-inflammatory cytokine, and specific promoter polymorphisms (including rs1800795) that increase its transcription have been associated with greater osteoarthritis susceptibility in meta-analyses, particularly for knee OA. Practically, this means some people are genetically inclined toward a more inflammatory response to joint stress or injury than others.
If the gene is bad, the plan without supplements: This is the clearest case where the hs-CRP section above becomes directly actionable — carriers of higher-IL-6 variants likely benefit more than average from consistent anti-inflammatory habits: regular zone 2 exercise, adequate sleep, and minimizing chronic added-sugar intake, since these all blunt the downstream inflammatory cascade IL-6 helps drive.
If the score is bad, the plan with supplements or equipment: Omega-3 fish oil (same dosing as above, 1.5-3g EPA/DHA daily) has the most direct evidence for dampening IL-6-driven inflammatory signaling specifically. No special cycling is required beyond periodic retesting of hs-CRP as a functional readout of whether it's working for you.
VDR (Vitamin D Receptor)
The VDR gene encodes the receptor vitamin D binds to in order to exert its effects. A TaqI polymorphism in this gene has been associated with roughly double the odds of early knee osteoarthritis in some studies, and separate research found a joint effect between VDR variants and low calcium intake on symmetrical OA risk — meaning the gene's impact depends heavily on your diet.
If the gene is bad, the plan without supplements: Because this variant affects how well your body uses vitamin D rather than how much you have, ensure adequate dietary calcium (dairy, leafy greens, fortified foods) alongside sun exposure, since the gene-diet interaction appears to matter more than either factor alone.
If the score is bad, the plan with supplements or equipment: If you carry this variant, it may be worth targeting a somewhat higher serum 25(OH)D level (within the normal safe range, discussed with your doctor) since receptor sensitivity may be reduced. Follow the same vitamin D3 and K2 dosing described above, and retest levels at 3 months rather than assuming standard dosing produces a standard response.
The Longevity Lens: What Outlive Gets Right About Joint Health
Peter Attia's book Outlive: The Science and Art of Longevity isn't written specifically about knee cartilage, but a significant portion of its "Medicine 3.0" framework directly challenges how most people think about joint problems like chondropathy — treating them as inevitable age-related decline rather than a trainable, largely modifiable system. Here are the ten ideas from the book most relevant to protecting a joint like the medial tibial plateau.
1. Muscle Is Medicine, Not Vanity
Attia frames muscle mass and strength not as aesthetic goals but as the primary buffer against joint injury and functional decline. For a knee with medial compartment cartilage loss, quad and hip strength directly determines how much force actually reaches the damaged cartilage during daily movement.2. VO2 Max Predicts More Than Cardiovascular Risk
Cardiorespiratory fitness is one of the strongest predictors of all-cause mortality in the longevity literature Attia cites, and it's also directly tied to how well you can sustain the low-impact cardio (cycling, swimming, incline walking) that protects joints while maintaining fitness.3. The "Centenarian Decathlon" Reframes Training Around Function
Attia's exercise philosophy asks readers to identify the specific physical tasks they want to still perform decades from now (carrying groceries upstairs, getting up off the floor) and train backward from there — a useful mental model for someone rehabbing a knee, since it reorients training around durability rather than short-term symptom relief.4. Stability And Balance Prevent The Injuries That Accelerate Joint Damage
A large share of joint deterioration Attia discusses isn't gradual wear — it's the compounding effect of falls, missteps, and acute injuries layered onto an already vulnerable joint. Balance and proprioception training is presented as an underrated injury-prevention tool, directly relevant to protecting a knee that's already lost some structural margin.5. Rate Of Force Development Matters As Much As Raw Strength
Attia emphasizes training the ability to generate force quickly, not just maximally, since this capacity declines faster with age and is what actually prevents a stumble from becoming a fall. This has direct relevance for anyone worried about a sudden misstep loading a damaged medial condyle.6. Zone 2 Training Builds The Metabolic Base That Protects Joints Indirectly
Consistent with the biomarker section above, Attia argues that most people spend too much time in either very easy or very hard exercise and too little in the aerobic base-building zone that most efficiently improves insulin sensitivity and mitochondrial health — both of which show up in this article's metabolic biomarkers.7. Nutritional Biochemistry Beats Nutritional Dogma
Rather than prescribing a single diet, Attia pushes readers toward tracking their own biomarkers (glucose, lipids, inflammatory markers) and adjusting individually — the same philosophy this article applies specifically to cartilage-related biomarkers.8. Sleep Is Treated As A Primary Lever, Not A Lifestyle Footnote
Poor sleep is linked throughout the book to worse metabolic and inflammatory markers — both of which this article's hs-CRP and insulin sections identify as directly relevant to cartilage health.9. Emotional Health Is Called "The Fourth Horseman" For A Reason
Attia argues chronic stress and poor emotional health erode the motivation and consistency needed to sustain the other three pillars (exercise, nutrition, sleep) — relevant because joint rehab plans fail most often from inconsistency, not from choosing the wrong exercise.10. Medicine 3.0 Means Acting Before The Damage Is Severe
The book's central argument is that waiting for a disease label (like advanced osteoarthritis) before intervening is a failure of the current medical model. Tracking biomarkers and addressing metabolic and inflammatory risk while cartilage loss is still early-to-moderate — which is exactly the situation most people with medial tibial condyle chondropathy are in — is the entire premise of a Medicine 3.0 approach.Complementary Approaches Backed By Real Studies
Several complementary approaches have specific clinical trial evidence in knee osteoarthritis, which is directly relevant to medial tibial condyle chondropathy given the shared mechanisms and outcome measures researchers use. The five below have the strongest and most condition-specific human evidence; results are generally modest and best viewed as adjuncts to strength training and load management, not replacements for it.
Tai Chi
Tai chi combines slow, controlled movement with weight-shifting and balance work, which makes it plausible for a joint like the medial tibial plateau, where control through range of motion — not just strength — affects how load is distributed across the cartilage surface. A large randomized trial published in Annals of Internal Medicine compared 12 weeks of group tai chi against standard physical therapy in 204 adults with knee osteoarthritis and found tai chi produced equivalent improvements in pain and function, with better results sustained at one year in some measures (Wang et al., Annals of Internal Medicine; summarized by NCCIH). A realistic approach is two structured 1-hour sessions per week for at least 12 weeks, ideally through a qualified instructor initially, since technique affects how much balance and loading benefit you actually get; it's low-risk for most people but should be modified around any acute knee flare.Yoga
Yoga's relevance here comes from its combination of strengthening, stretching, and alignment-focused postures, several of which can be adapted to reduce medial compartment loading while building the surrounding hip and quad strength this article's biomarker sections repeatedly point back to. A pilot study of modified Iyengar yoga in previously yoga-naive adults over 50 with knee osteoarthritis found statistically significant improvements in pain and disability after eight weekly 90-minute sessions (Kolasinski et al., Journal of Alternative and Complementary Medicine); a separate trial combining Iyengar yoga with EMG biofeedback found additional benefit over yoga alone (study on combined yoga and biofeedback). Start with a certified instructor experienced in working around joint limitations, avoid deep unsupported knee flexion postures initially, and expect it to function as a strength-and-mobility adjunct rather than a standalone fix.Massage Therapy
Massage is relevant less for cartilage biology directly and more for the muscular guarding and compensatory tension that often develops around a painful knee, which can itself alter gait and increase medial compartment loading over time. A randomized dose-finding trial found that standard Swedish massage delivered weekly or biweekly over eight weeks produced meaningful improvements in pain and function scores for knee osteoarthritis, with 60-minute weekly sessions performing best among the doses tested (Perlman et al., dose-finding RCT). A practical starting point is one 30-60 minute session weekly for 8 weeks, reassessing pain and function before deciding whether to continue; risk is low but rare cases of clot or nerve irritation have been reported, per NCCIH's massage therapy overview.Photobiomodulation (Low-Level Laser Therapy)
Photobiomodulation uses specific wavelengths of light theorized to reduce local inflammation and modulate pain signaling at the joint, making it one of the few complementary approaches aimed directly at the joint tissue itself rather than surrounding muscle or general stress reduction. Evidence is genuinely mixed: an earlier meta-analysis of nine RCTs found no significant difference in pain scores immediately after treatment when studies followed recommended dosing parameters (systematic review and meta-analysis), while more recent trials combining it with exercise therapy have shown clearer benefit, suggesting it may work best as an adjunct rather than standalone treatment. Given the mixed evidence, this is reasonable to try as an add-on to an existing exercise program (typically administered in a clinical setting 2-3x weekly for several weeks) rather than a primary strategy, and expectations should be modest.Biofeedback
EMG biofeedback trains awareness and control of specific muscle activation patterns, which is relevant to a joint condition where altered quad activation and compensatory movement patterns are common and can perpetuate uneven loading across the tibial plateau. The trial referenced above under yoga found that adding EMG biofeedback to an Iyengar yoga program produced greater improvement in pain and functional disability than yoga alone in people with chronic unilateral knee osteoarthritis (combined yoga and biofeedback trial). This is best accessed through a physical therapist with biofeedback equipment rather than attempted alone, typically over several weeks alongside a structured strengthening program; it carries essentially no physical risk, though it requires consistent session attendance to see benefit.Conclusion
Medial tibial condyle chondropathy isn't just a mechanical problem with a mechanical fix. The biomarkers covered here — inflammatory, metabolic, and cartilage-specific — give a far more complete picture of what's actually driving cartilage breakdown than pain scores or imaging alone, and each one comes with a realistic, evidence-based way to move it in the right direction, with or without supplements. The genetic variants are worth knowing but rarely worth worrying over; they shift baseline risk modestly and are almost always outweighed by what you actually do day to day. The complementary approaches with real trial support — tai chi, yoga, massage, biofeedback, and cautiously, photobiomodulation — work best layered onto strength training and load management, not instead of it.
The most useful next step is a practical one: get a baseline panel (start with the affordable tests — hs-CRP, fasting insulin, HbA1c, and vitamin D), track how your knee actually responds to load changes over a few weeks, and bring both sets of information to a physical therapist or orthopedic clinician who can connect the lab data to what's happening structurally in your joint. That combination — objective numbers plus a professional read on your specific knee — is a far stronger starting point than generic advice alone.